Eris Lifesciences shareholders and shareholding pattern
NSE: ERISBSE: 540596Pharmaceuticals & BiotechnologySmall Cap
Last close ₹1,095.50down ₹25.70 (2.29%)BSE ₹1,097.65
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,121.20.
52-week range of traded prices to 23 Oct 2026
₹1,087.90Low, 23 Oct 2026₹1,740.00High, 9 Dec 2025
- Next results date: the board meets on 26 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹15,199 Cr353rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 29 Jul 2026
- 23.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 20 May 2026
- 3.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.66%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 29 Jul 2026
- 19.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 29 Jul 2026
- 13.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 20 May 2026
- 0.59
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 37,94348.8% delivered
Who owns Eris Lifesciences, filing by filing
Per cent of the company's shares. Every filing on record, from Jun 2017; the latest is the filing for Sep 2026.
Sep 2026 filing
- Promoters54.74%
- Foreign institutions5.74%
- Indian institutions20.20%
- GovernmentsNone
- Individuals and others19.32%
Shareholding pattern, per cent, from Sep 2022
- Promoters
- Foreign institutions
- Indian institutions
- Governments
- Individuals and others
| Per cent | Jun 2017Filed 30 Mar | Sep 2017Filed 30 Mar | Dec 2017Filed 18 Jan | Mar 2018Filed 13 Apr | Jun 2018Filed 10 Jul | Sep 2018Filed 20 Oct | Dec 2018Filed 11 Jan | Mar 2019Filed 6 Apr | Jun 2019Filed 18 Jul | Sep 2019Filed 16 Oct | Dec 2019Filed 18 Jan | Mar 2020Filed 16 Apr | Jun 2020Filed 18 Jul | Sep 2020Filed 20 Oct | Dec 2020Filed 20 Jan | Mar 2021Filed 20 Apr | Jun 2021Filed 21 Jul | Sep 2021Filed 18 Oct | Dec 2021Filed 21 Jan | Mar 2022Filed 20 Apr | Jun 2022Filed 15 Jul | Sep 2022Filed 12 Oct | Dec 2022Filed 20 Jan | Mar 2023Filed 21 Apr | Jun 2023Filed 10 Jul | Sep 2023Filed 17 Oct | Dec 2023Filed 18 Jan | Mar 2024Filed 16 Apr | Jun 2024Filed 11 Jul | Sep 2024Filed 18 Oct | Dec 2024Filed 20 Jan | Mar 2025Filed 19 Apr | Jun 2025Filed 19 Jul | Sep 2025Filed 18 Oct | Dec 2025Filed 15 Jan | Mar 2026Filed 15 Apr | Jun 2026Filed 18 Jul | Sep 2026Filed 19 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 55.93% | 55.93% | 55.93% | 55.93% | 55.93% | 55.92% | 56.04% | 56.10% | 56.23% | 56.23% | 56.23% | 55.55% | 55.55% | 54.08% | 54.23% | 54.13% | 52.69% | 52.68% | 52.66% | 52.66% | 52.30% | 52.29% | 52.70% | 52.86% | 52.86% | 54.91% | 54.90% | 54.90% | 54.88% | 54.87% | 54.86% | 54.85% | 54.83% | 54.85% | 54.85% | 53.92% | 54.14% | 54.74% | |
| Indian promoters | 55.93% | 55.93% | 55.93% | 55.93% | 55.93% | 55.92% | 56.04% | 56.10% | 56.23% | 56.23% | 56.23% | 55.55% | 55.55% | 54.08% | 54.23% | 54.13% | 52.69% | 52.68% | 52.66% | 52.66% | 52.30% | 52.29% | 52.70% | 52.86% | 52.86% | 54.91% | 54.90% | 54.90% | 54.88% | 54.87% | 54.86% | 54.85% | 54.83% | 54.85% | 54.85% | 53.92% | 54.14% | 54.74% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. | 44.07% | 44.07% | 44.07% | 44.06% | 44.07% | 44.08% | 43.96% | 43.90% | 43.77% | 43.77% | 43.77% | 44.45% | 44.45% | 45.92% | 45.77% | 45.87% | 47.31% | 47.32% | 47.34% | 47.34% | 47.70% | 47.71% | 47.30% | 47.14% | 47.14% | 45.09% | 45.10% | 45.10% | 45.12% | 45.13% | 45.14% | 45.15% | 45.17% | 45.15% | 45.15% | 46.08% | 45.86% | 45.26% |
| Promoter shares pledgedShare of the promoters' own shares | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 11.37% | 10.95% | 10.95% | 18.51% | 18.51% | 18.51% | 18.51% | 18.51% | 16.93% | 16.92% | 16.92% | 16.92% | 16.85% | 21.25% |
| Shares in issue | 13,75,00,000 | 13,75,00,000 | 13,75,00,000 | 13,75,00,000 | 13,75,05,486 | 13,75,15,461 | 13,75,17,622 | 13,75,19,783 | 13,75,19,783 | 13,75,19,783 | 13,75,19,783 | 13,57,80,653 | 13,57,80,653 | 13,57,80,653 | 13,57,80,653 | 13,57,80,653 | 13,57,80,653 | 13,59,08,589 | 13,59,30,197 | 13,59,30,197 | 13,59,72,680 | 13,59,90,717 | 13,59,90,717 | 13,59,92,238 | 13,59,93,292 | 13,60,23,248 | 13,60,28,280 | 13,60,28,280 | 13,60,75,008 | 13,61,05,792 | 13,61,29,282 | 13,61,62,569 | 13,61,97,325 | 13,62,13,554 | 13,62,16,891 | 13,85,42,887 | 13,85,78,489 | 13,87,38,569 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. | 12,15,51,250 | 10,86,25,000 | 10,86,25,000 | 10,86,25,000 | 2,75,00,000 | 2,75,00,000 | 2,75,00,000 | 2,75,00,000 | 2,75,00,000 | 2,75,00,000 | 2,75,00,000 | 2,75,00,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | – | – | – | 23,06,372 | 23,06,372 | 23,06,372 |
| Promoters' shares locked in | 7,69,04,500 | 7,69,04,500 | 7,69,04,500 | 7,69,04,500 | 2,75,00,000 | 2,75,00,000 | 2,75,00,000 | 2,75,00,000 | 2,75,00,000 | 2,75,00,000 | 2,75,00,000 | 2,75,00,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | – | – | – | – | – | – |
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. Pledged is the share of the promoters' own shares given to lenders as security. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Eris Lifesciences promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is Amit Indubhusan Bakshi, 42.96%. The filing names 56 more members with no shares.Promoter buying and selling
| Holder | |||
|---|---|---|---|
| Amit Indubhusan BakshiIndividuals and Hindu undivided families | 42.96% | 5,95,96,636 | 19.59% |
| Inderjeet Singh NegiIndividuals and Hindu undivided families | 4.28% | 59,39,833 | 31.69% |
| Rajendrakumar Rambhai PatelIndividuals and Hindu undivided families | 4.28% | 59,39,834 | 31.69% |
| Kaushal Kamleshkumar ShahIndividuals and Hindu undivided families | 3.22% | 44,68,833 | 15.66% |
| Sarthak NegiIndividuals and Hindu undivided families | 0.00% | 100 | 0.00% |
Pledged is the share of the holder's own shares pledged to a lender.
Largest public holders of Eris Lifesciences, filing by filing
Per cent, on the same shares as the split above.Mutual funds holding Eris Lifesciences
| Holder | Jun 2017Filed 30 Mar | Sep 2017Filed 30 Mar | Dec 2017Filed 18 Jan | Mar 2018Filed 13 Apr | Jun 2018Filed 10 Jul | Sep 2018Filed 20 Oct | Dec 2018Filed 11 Jan | Mar 2019Filed 6 Apr | Jun 2019Filed 18 Jul | Sep 2019Filed 16 Oct | Dec 2019Filed 18 Jan | Mar 2020Filed 16 Apr | Jun 2020Filed 18 Jul | Sep 2020Filed 20 Oct | Dec 2020Filed 20 Jan | Mar 2021Filed 20 Apr | Jun 2021Filed 21 Jul | Sep 2021Filed 18 Oct | Dec 2021Filed 21 Jan | Mar 2022Filed 20 Apr | Jun 2022Filed 15 Jul | Sep 2022Filed 12 Oct | Dec 2022Filed 20 Jan | Mar 2023Filed 21 Apr | Jun 2023Filed 10 Jul | Sep 2023Filed 17 Oct | Dec 2023Filed 18 Jan | Mar 2024Filed 16 Apr | Jun 2024Filed 11 Jul | Sep 2024Filed 18 Oct | Dec 2024Filed 20 Jan | Mar 2025Filed 19 Apr | Jun 2025Filed 19 Jul | Sep 2025Filed 18 Oct | Dec 2025Filed 15 Jan | Mar 2026Filed 15 Apr | Jun 2026Filed 18 Jul | Sep 2026Filed 19 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lilac Investments LimitedForeign companies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 7.26% | 8.79% | 8.79% | 8.79% | 8.78% | 8.78% | 8.64% | 8.63% | 8.62% |
| Hetal Rasiklal ShahResident individuals, over ₹2 lakh at face value | 3.50% | 3.50% | 3.50% | 3.50% | 3.50% | 3.50% | 3.50% | 3.50% | 3.48% | 3.48% | 2.97% | 2.97% | 2.96% | 2.89% | 2.85% | 2.81% | 2.72% | 2.69% | 2.69% | 2.69% | 2.68% | 2.68% | 2.68% | 2.68% | 2.68% | 2.62% | 2.58% | 2.58% | 2.40% | 2.20% | 2.20% | 2.20% | 2.18% | 2.16% | 2.16% | 2.12% | 2.12% | 2.12% |
| Bhikhalal Chimanlal ShahResident individuals, over ₹2 lakh at face value | 8.04% | 8.04% | 8.04% | 8.04% | 8.04% | 7.76% | 7.76% | 7.76% | 7.76% | 7.76% | 6.60% | 6.55% | 6.55% | 6.55% | 6.55% | 6.55% | 6.53% | 6.53% | 6.52% | 6.52% | 4.32% | 4.32% | 4.32% | 4.32% | 4.31% | 4.30% | 4.30% | 2.76% | 2.76% | 1.97% | 1.97% | 1.97% | 1.97% | 1.97% | 1.97% | 1.93% | 1.93% | 1.93% |
| Naishadh Vikram ShahResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.66% | 1.66% | 1.66% |
| Rakesh ShahResident individuals, over ₹2 lakh at face value | – | – | – | 11.53% | 11.53% | 11.53% | 11.53% | 11.53% | 11.53% | 11.53% | 11.53% | 11.55% | 11.55% | 11.55% | 11.55% | 11.55% | 11.55% | 11.54% | 11.54% | 11.54% | 11.53% | 11.53% | 11.53% | 11.53% | 11.53% | 4.88% | 4.88% | 4.88% | 4.88% | 2.92% | 1.45% | 1.45% | 1.45% | 1.45% | 1.45% | 1.43% | 1.43% | 1.42% |
| Emerald Investments LimitedForeign portfolio investors, category I | – | – | – | – | – | – | – | – | – | – | 2.60% | 5.51% | 5.51% | 5.51% | 5.51% | 5.51% | 5.51% | 5.50% | 5.50% | 5.50% | 7.58% | 7.58% | 7.58% | 7.58% | 7.58% | 7.58% | 7.58% | 7.27% | 7.27% | – | – | – | – | – | – | – | – | – |
| Plutus Wealth Management LlpCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.10% | 1.10% | – | – | – | – | – | – | – | – | – | – | – |
| Kuwait Investment Authority Fund 225Foreign portfolio investors, category I | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.11% | 1.11% | – | – | – | – | – | – | – | 1.47% | 1.47% | 1.47% | 1.10% | 1.03% | – | – | – | – | – | – | – | – | – | – | – |
| UTI India Dynamic Equity FundForeign portfolio investors, category II | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.06% | 1.00% | – | 1.02% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Fundsmith Emerging Equities Trust PlcInstitutions Foreign Portfolio Investor | – | – | – | – | – | – | – | – | 1.11% | 1.11% | 1.11% | 1.09% | 1.09% | 1.09% | 1.09% | 1.09% | 1.09% | 1.09% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Abu Dhabi Investment Authority - BehaveInstitutions Foreign Portfolio Investor | – | 1.01% | 1.01% | 1.01% | 1.01% | 1.01% | 1.01% | 1.01% | 1.01% | 1.01% | 1.01% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Matthews India FundInstitutions Foreign Portfolio Investor | – | – | – | 1.02% | 1.42% | 1.42% | 1.42% | 1.42% | 1.15% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Goldman Sachs India LimitedInstitutions Foreign Portfolio Investor | 1.99% | 1.65% | 1.65% | 1.37% | 1.31% | 1.20% | 1.20% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Rakeshbhai Bhikhabhai ShahResident individuals, over ₹2 lakh at face value | 11.53% | 11.53% | 11.53% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Merrill Lynch Markets Singapore Pte. LtdInstitutions Foreign Portfolio Investor | 1.15% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. Mutual funds are left out here: each fund's holding is on the Mutual funds tab, from its own portfolio. A dash is a filing that did not name the holder, which includes holding under one per cent.